Bio-Rad Laboratories Class B
BIO.B
6 hedge funds and large institutions have $7.55M invested in Bio-Rad Laboratories Class B in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
7% more capital invested
Capital invested by funds: $7.03M → $7.55M (+$519K)
0% more funds holding
Funds holding: 6 → 6 (0)
0% more ownership
Funds ownership: 0.61% → 0.61% (0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$24.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$24.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $5.32M | – | – | – |
|
2
Dimensional Fund Advisors
Austin,
Texas
| $1.66M | – | – | – |
|
3
Renaissance Technologies
New York
| $262K | – | – | – |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $246K | +$24.1K | +100 | +11% |
|
|
5
UBS Group
Zurich,
Switzerland
| $64K | -$24.1K | -100 | -27% |
|
6
Bank of America
Charlotte,
North Carolina
| $1K | – | – | – |
|
BIO.B Hedge Fund Activity: Q4 2017 in Review
6 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q4 2017, worth a combined $7.55M — up 7.4% from $7.03M a quarter earlier.
Fund positioning in BIO.B was balanced in Q4 2017: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $24.1K. The largest seller was UBS Group, cutting an estimated $24.1K.
- 6 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q4 2017, unchanged from Q3 2017.
- Funds reported $7.55M of Bio-Rad Laboratories Class B stock for Q4 2017, up 7.4% quarter-over-quarter.
- 0 funds opened new Bio-Rad Laboratories Class B positions in Q4 2017 and 0 closed out.
- The largest Bio-Rad Laboratories Class B buyer in Q4 2017 was Susquehanna International Group, an estimated $24.1K added.
- The largest Bio-Rad Laboratories Class B seller in Q4 2017 was UBS Group, an estimated $24.1K sold.
Based on aggregated 13F filings for Q4 2017.